可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Abbo KM, Dooris M, Glazier S. Features and outcome of no-reflow after percutaneous coronary intervention[J]. Am J Cardiol, 1995, 75(12):778-782.
[2]Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of “no-reflow” after percutaneous coronary intervention[J]. Circulation, 1994, 89(6):2514-2518.
[3]Jaffe R, Charron T, Puley G, et al. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention[J]. Circulation, 2008, 117(24):3152-3156.
[4]Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[J]. Circulation, 2002, 105(18):2148-2152.
[5]Liu DD, Hsieh NK, Chen HI. Histopathological and biochemical changes following fat embolism with administration of corn oil micelles:a new animal model for fat embolism syndrome: a new animal model for fat Embolism syndrome[J]. J Bone Joint Surg Br, 2008, 90(11):1517-1521.
[6] Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to Thrombolysis In Myocardial Infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J]. Circulation, 1996, 93(11):1993-1999.
[7]Webb JG, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention[J]. J Am Coll Cardiol, 1999, 34(2):468-475.
[8]Jouven X, Charles MA, Desnos M, et al. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population[J]. Circulation, 2001, 104(7):756-761.